Atrial fibrillation (AF) has become a chronic disease seriously threatening the health of the elderly, and its most common complications are systemic embolism and other vascular embolic events, with higher morbidity and mortality. However, anticoagulant therapy is underused in elderly adults with AF in the clinical practice, so it is of great importance to adopt aniticoagulant therapy for them.